(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.82%) $83.16
(-1.16%) $1.619
(-0.39%) $2 338.00
(0.82%) $27.48
(0.49%) $926.60
(-0.19%) $0.933
(-0.20%) $11.00
(-0.27%) $0.798
(0.00%) $92.17
Live Chart Being Loaded With Signals
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases...
Stats | |
---|---|
Šios dienos apimtis | 28 356.00 |
Vidutinė apimtis | 15 071.00 |
Rinkos kapitalizacija | 2.67M |
EPS | $0 ( 2024-04-01 ) |
Kita pelno data | ( $-0.940 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0600 |
ATR14 | $0.0750 (1.37%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-09-27 | Fraser Craig | Buy | 2 500 | Common Stock |
2023-09-26 | Fraser Craig | Buy | 2 500 | Common Stock |
2023-08-24 | Mcandrew Jamie | Sell | 0 | Common Stock |
2023-08-24 | Mcandrew Jamie | Buy | 0 | Common Stock |
2023-08-24 | Mcandrew Jamie | Sell | 220 | Employee Stock Option (Right to Buy) |
INSIDER POWER |
---|
36.21 |
Last 96 transactions |
Buy: 7 918 771 | Sell: 11 081 644 |
Tūris Koreliacija
Windtree Therapeutics Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
MIGI | 0.974 |
NAOV | 0.968 |
VYNE | 0.941 |
SNGX | 0.922 |
XM | 0.921 |
STX | 0.917 |
DRNA | 0.912 |
SHIP | 0.909 |
TREE | 0.903 |
SUMO | 0.901 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
GMII | -0.909 |
XPDI | -0.892 |
WASH | -0.87 |
ATSG | -0.86 |
AKAM | -0.859 |
EAR | -0.854 |
CSGP | -0.854 |
CCSI | -0.849 |
AFYA | -0.848 |
ALHC | -0.847 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Windtree Therapeutics Inc Koreliacija - Valiuta/Žaliavos
Windtree Therapeutics Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $0 |
Bruto pelnas: | $-82 000.00 (0.00 %) |
EPS: | $-94.23 |
FY | 2023 |
Pajamos: | $0 |
Bruto pelnas: | $-82 000.00 (0.00 %) |
EPS: | $-94.23 |
FY | 2022 |
Pajamos: | $0 |
Bruto pelnas: | $-1.06M (0.00 %) |
EPS: | $-62.23 |
FY | 2021 |
Pajamos: | $0.00 |
Bruto pelnas: | $0.00 (0.00 %) |
EPS: | $-2.73 |
Financial Reports:
No articles found.
Windtree Therapeutics Inc
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF, an aerosolized KL4 surfactant, which is in Phase IIb clinical trial to treat respiratory distress syndrome in premature infants; Lyophilized KL4 surfactant, which is in Phase IIa clinical trial for the treatment of lung injury resulting from COVID-19; and Rostafuroxin that is in Phase IIb clinical trial for the treatment of genetically associated hypertension. It has a collaboration with Universita degli Studi di Milano-Bicocca for the discovery and development of new SERCA2a compounds for the treatment of chronic and acute human heart failure; a strategic alliance with Laboratorios del Dr. Esteve, S.A. for the development, marketing, and sales of a portfolio of potential KL4 surfactant products; and collaboration with Battelle Memorial Institute for development of its ADS for use in its phase III program. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. Windtree Therapeutics, Inc. was incorporated in 1992 and is headquartered in Warrington, Pennsylvania. Windtree Therapeutics, Inc. is a subsidiary of Lee's Pharmaceutical Holdings Limited.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.